Cryosite Ltd

Cryosite Ltd

CTE · AU · Healthcare / Diagnostics & Research

1.22AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close1.22
Open1.22
Day Range1.22 – 1.22
52-Week Range0.84 – 1.40
Volume0
Market Cap56.13M
P/E (TTM)28.75
Forward P/E10.47
EPS0.04
Dividend Yield0.00%
Beta0.16
50-Day Avg1.21
200-Day Avg1.14

About

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements. The Ultra-frozen and cryogenic segment offers advanced therapy medicinal products (ATMPS), such as cell and gene therapies (CGT), cell therapies, mRNA-based medicines, biological samples, and research and development materials requiring high-integrity cold storage. The Cord Blood segment provides storage of cord blood cell and tissue samples for personal or directed therapeutic use by maintaining under validated chain-of-identity controls. It also offers reverse logistics services, secondary packaging, inventory management, and quality transportation and distribution solutions. Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMs. Jane Hao
  • Employees27
  • Headquarters13a Ferndell Street, South Granville, NSW, Australia, 2142, Australia
  • Websitehttps://www.cryosite.com

Leadership

  • Ms. Jane HaoChief Financial Officer
  • Mr. Andrew KerrExecutive Director
  • Ms. Alicia SteelGeneral Manager
  • Mr. Jon StearnsOperations Manager
  • Mr. Hamish GeorgeCompany Secretary

Financials

Income Statement

Currency: AUD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue2.43K461.00K1.90M2.09M2.96M4.10M4.72M6.47M6.16M5.97M6.43M7.76M8.50M9.17M9.59M10.04M5.81M5.86M7.91M8.92M10.02M11.76M11.94M12.61M14.12M16.70M
Growth (%)-+18894.64%+312.73%+9.99%+41.20%+38.65%+15.27%+36.95%-4.78%-3.08%+7.78%+20.59%+9.54%+7.92%+4.62%+4.68%-42.11%+0.86%+34.92%+12.74%+12.38%+17.29%+1.52%+5.67%+11.93%+18.31%
Cost of Revenue43.32K646.51K1.24M1.24M1.72M2.11M2.33M3.28M3.17M3.28M3.42M3.91M4.07M4.56M5.40M6.02M2.87M2.54M4.60M5.41M4.72M5.48M5.46M4.62M5.23M7.19M
Gross Profit-40.89K-185.51K660.13K852.32K1.24M1.99M2.40M3.19M2.98M2.69M3.01M3.85M4.43M4.61M4.20M4.02M2.95M3.33M3.31M3.51M5.31M6.27M6.48M7.99M8.89M9.51M
Gross Margin-1684.80%-40.24%34.69%40.73%41.85%48.46%50.73%49.26%48.46%45.06%46.83%49.61%52.12%50.30%43.76%40.05%50.67%56.77%41.82%39.36%52.93%53.36%54.28%63.38%62.98%56.96%
Operating Expense1.07M1.29M2.20M2.15M2.26M2.35M2.38M3.39M3.53M3.12M3.42M3.64M3.51M4.18M3.80M3.68M3.04M3.07M3.33M2.80M4.24M4.38M4.95M5.94M6.39M6.35M
Operating Income-1.11M-1.48M-1.54M-1.30M-1.03M-367.09K14.20K-206.83K-547.30K-430.89K-412.04K206.53K922.17K434.73K398.53K346.44K-89.99K259.44K-18.90K712.19K1.06M1.89M1.52M2.05M2.50M3.16M
Operating Margin-45910.59%-320.73%-81.05%-62.12%-34.72%-8.96%0.30%-3.20%-8.89%-7.22%-6.41%2.66%10.85%4.74%4.15%3.45%-1.55%4.42%-0.24%7.98%10.60%16.09%12.77%16.29%17.68%18.92%
EBITDA-930.77K-993.60K-902.98K-733.13K-309.45K432.61K573.19K899.22K-5.73K312.54K807.32K1.59M1.76M1.28M1.23M932.75K-234.91K259.44K252.12K2.11M1.65M2.40M2.30M3.04M3.41M4.07M
EBITDA Margin-38350.52%-215.53%-47.46%-35.03%-10.47%10.56%12.14%13.90%-0.09%5.24%12.55%20.43%20.76%13.91%12.77%9.29%-4.04%4.42%3.19%23.64%16.47%20.42%19.25%24.07%24.19%24.38%
Net Income-984.99K-1.22M-1.17M-950.04K-620.31K101.37K922.74K447.06K7.25K4.61K334.31K1.02M1.25M505.60K455.17K302.47K-142.11K-244.70K-565.16K1.48M652.57K1.36M1.41M1.84M1.88M2.23M
Net Income Margin-40584.71%-265.51%-61.49%-45.39%-20.99%2.47%19.54%6.91%0.12%0.08%5.20%13.18%14.71%5.51%4.74%3.01%-2.44%-4.17%-7.14%16.59%6.51%11.60%11.81%14.59%13.35%13.38%
R&D--------308.00K--308.00K--4.65K17.70K47.64K50.64K--------
R&D as % of Total Revenue--------5.00%--3.97%--0.05%0.18%0.82%0.86%--------
Interest Expense1.41K7.00K11.88K5.01K9.65K9.49K8.30K8.40K12.19K13.53K11.28K10.21K7.83K6.60K2.42K000600.25K20100.48K81.34K65.00K163.00K20.00K336.00K
Interest Expense % of Total Revenue58.14%1.52%0.62%0.24%0.33%0.23%0.18%0.13%0.20%0.23%0.18%0.13%0.09%0.07%0.03%0.00%0.00%0.00%7.59%0.00%1.00%0.69%0.54%1.29%0.14%2.01%

Balance Sheet

Currency: AUD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets4.05M4.36M3.52M4.40M4.66M5.11M6.40M7.25M7.35M7.68M8.63M9.77M11.36M11.19M9.12M9.66M9.83M7.74M23.17M23.50M21.99M21.50M22.65M19.71M19.46M25.97M
Total Liabilities179.70K469.00K754.78K1.36M2.18M2.30M2.66M2.93M3.01M3.33M3.93M4.29M5.10M5.06M5.58M6.28M6.68M5.80M24.89M23.35M21.17M19.64M19.86M18.26M17.07M21.12M
Total Equity3.87M3.89M2.77M3.04M2.48M2.81M3.74M4.32M4.34M4.35M4.69M5.48M6.26M6.14M3.54M3.38M3.15M1.94M-1.72M154.88K819.23K1.86M2.78M1.45M2.39M4.85M
Cash2.75M2.90M1.64M2.08M1.35M1.30M1.58M1.98M1.33M2.05M2.91M4.52M5.78M6.25M4.17M3.65M5.09M4.54M3.92M4.06M3.88M5.34M4.73M4.70M5.06M2.24M
Total Debt6.93K5.10K1.16K---------------1.26M1.26M1.07M849.77K2.61M2.44M2.27M7.72M
Net Debt-2.75M-2.89M-1.63M-2.08M-1.35M-1.30M-1.58M-1.98M-1.33M-2.05M-2.91M-4.52M-5.78M-6.25M-4.17M-3.65M-5.09M-4.54M-3.92M-2.80M-2.82M-4.49M-2.13M-2.26M-2.79M5.47M

Cash Flow

Currency: AUD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-933.52K-1.20M--738.72K-199.90K-203.02K697.65K888.27K709.86K977.66K1.42M1.88M1.94M1.58M1.42M474.61K1.63M-261.91K-647.54K1.31M476.96K2.49M1.41M2.74M2.06M2.73M
Investing Cash Flow-1.11M-195.00K-295.27K-191.89K-455.08K-63.39K-417.94K-494.51K-1.36M-259.38K-553.48K-43.88K-211.60K-475.25K-472.95K-504.69K-220.69K-139.10K31.61K-909.85K-396.89K-863.19K-1.22M727.00K-420.00K-10.87M
Financing Cash Flow-5.13K3.80M-3.94K1.37M-72.96K219.86K-69-----222.52K-475.73K-634.64K-3.03M-485.63K31.43K-254.60K-254.60K-254.60K-260.78K-148.99K-796.00K-3.50M-1.29M5.33M
Capital Expenditure1.11M195.00K307.46K193.15K455.08K63.39K417.94K494.51K1.36M274.38K696.50K181.66K350.66K413.81K361.88K358.34K178.80K180.78K26.16K909.85K396.89K863.19K301.00K452.00K586.00K10.87M
Free Cash Flow-2.05M-1.39M-307.46K-931.87K-654.98K-266.41K279.71K393.76K-648.49K703.27K722.86K1.70M1.59M1.17M1.06M116.26K1.45M-442.69K-673.69K396.54K80.07K1.63M1.11M2.44M1.48M-8.14M
Dividends Paid-3.56K---------222.52K475.73K700.64K685.86K485.63K468.57K00488.00K488.00K488.00K488.00K732.00K976.00K-
FCF to OCF219.10%116.32%-126.15%327.65%131.22%40.09%44.33%-91.35%71.93%50.93%90.34%81.92%73.89%74.46%24.50%89.01%169.03%104.04%30.35%16.79%65.40%78.62%89.14%71.61%-298.35%
Dividend Paid to FCF--0.26%---------13.10%29.94%59.82%65.01%417.70%32.36%0.00%0.00%123.07%609.46%29.91%44.08%29.94%66.04%-

Earnings

Report DateFeb 24, 2016Aug 24, 2016Feb 22, 2017Aug 23, 2017Feb 28, 2018Aug 29, 2018Feb 26, 2019Aug 21, 2019Feb 27, 2020Aug 27, 2020Feb 25, 2021Aug 24, 2021Feb 22, 2022Aug 26, 2022Feb 24, 2023Feb 20, 2025Aug 18, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00-0.00--0.00-
EPS Actual0.000.000.000.000.00-0.010.00-0.010.030.000.010.010.020.010.010.020.02
Surprise-----------------
Timing------------After-hoursPre-marketPre-market-Pre-market

Key Statistics & Ratios

Market Cap56.13M
Enterprise Value63.07M
Trailing P/E28.75
Forward P/E10.47
PEG Ratio1.53
Price / Sales3.36
Price / Book11.88
EPS0.04
Book Value0.099
Revenue (TTM)16.70M
Gross Profit (TTM)10.43M
EBITDA3.55M
Profit Margin13.38%
Operating Margin18.77%
Return on Equity61.75%
Return on Assets8.69%
Shares Outstanding48.81M
Shares Float11.43M
Beta0.16
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20242×
0.02Sep 6, 20240.05Feb 21, 2024
20231×
0.01Sep 7, 2023
20221×
0.01Sep 15, 2022
20171×
0.01Mar 14, 2017
20162×
0.01Sep 7, 20160.01Mar 11, 2016
20152×
0.01Sep 8, 20150.01Mar 13, 2015
20142×
0.01Sep 8, 20140.01Mar 17, 2014
20132×
0.01Sep 23, 20130.01Mar 18, 2013
20122×
0.01Sep 28, 20120.01Mar 16, 2012

Stock Splits

  • Apr 29, 20041.0606:1